Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a<i>BRCA1</i>or<i>BRCA2</i>Gene Alteration

Wassim Abida, Akash Patnaik, David Campbell, Jeremy Shapiro, Alan H. Bryce, Ray McDermott, Brieuc Sautois, Nicholas J. Vogelzang, Richard Bambury, Éric Voog, Jingsong Zhang, Josep M. Piulats, Charles J. Ryan, Axel S. Merseburger, Gedske Daugaard, Axel Heidenreich, Karim Fizazi, Celestia S. Higano, Laurence E. Krieger, Cora N. Sternberg, Simon P. Watkins, Darrin Despain, Andrew D. Simmons, Andrea Loehr, Melanie Dowson, Tony Golsorkhi, Simon Chowdhury, on behalf of the TRITON2 investigators

Journal of Clinical Oncology, 2020

Memorial Sloan Kettering Cancer Center, University of Chicago, Geelong Hospital, Barwon Health, Cabrini Hospital, Mayo Clinic Hospital, Tallaght University Hospital, Centre Hospitalier Universitaire de Liège, Comprehensive Cancer Centers of Nevada, Cork University Hospital, Centre Jean Bernard, Clinique Victor Hugo, Moffitt Cancer Center, Institut Català d'Oncologia, University of Minnesota, University of Lübeck, Rigshospitalet, Copenhagen University Hospital, University Hospital Cologne, Université Paris-Saclay, Institut Gustave Roussy, Fred Hutch Cancer Center, University of Washington, Northern Cancer Institute, Weill Cornell Medicine, Presbyterian Hospital, Cornell University, Clovis Oncology (United States), Clovis Oncology (United Kingdom), Guy's Hospital, Sarah Cannon Research Institute

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with Journal of Clinical Oncology. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

667

Citations

View on Google Scholar

Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a<i>BRCA1</i>or<i>BRCA2</i>Gene Alteration

Abstract

Journal Details

Join JournalsHub

Welcome Back